Benzinga
Benzinga
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Benzinga
lunes, octubre 19
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Mangoceuticals Inc
MGRX
NASDAQ
Lista de seguimiento
Get Report
Trade with Public
Get Report
Trade with Public
$0.2899
-0.0311
-9.69%
Últ. Act.: Oct 19, 6:41 AM
$0.2985
-0.0225
-7.01%
Get Report
Panorámica general
Noticias
Previsión de beneficios
Finanzas
Sentimiento
Propiedad
Comparar
Informe de acciones
Privacy Manager
Mangoceuticals Financials
Mangoceuticals (MGRX) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
Stock Market Today: S&P 500, Dow Jones Futures Gain as Investors Await September's Jobs Report Data — NKE, SYNA, CTVA in Focus
U.S. stock futures advanced on Friday, as the Dow Jones, S&P 500 and Nasdaq 100 indices rose, following Thursday's higher close.
Rishabh Mishra
Nike, Synaptics And 3 Stocks To Watch Heading Into Friday
Nike falls on weak revenue; Synaptics jumps on $123 ON deal; AsiaStrategy surges on tokenization pact; Mangoceuticals drops.
Avi Kapoor
PRO
Mangoceuticals Q4 EPS $(0.13) Up From $(1.01) YoY, Sales $94.360K Down From $105.247K YoY
Mangoceuticals (NASDAQ:MGRX) reported quarterly losses of $(0.13) per share. This is a 87.13 percent increase over losses of $(1.01) per share from the same period last year. The company reported $94.360 thousand in
Benzinga Newsdesk
Nasdaq Surges Over 1%; Lamb Weston Shares Decline Following Q2 Results
Avi Kapoor
PRO
Mangoceuticals Q2 EPS $(0.57) Up From $(1.35) YoY, Sales $168.109K Up From $163.163K YoY
Mangoceuticals (NASDAQ:MGRX) reported quarterly losses of $(0.57) per share. This is a 57.78 percent increase over losses of $(1.35) per share from the same period last year. The company reported $168.109 thousand in
Benzinga Newsdesk
PRO
Mangoceuticals On Aug. 14 Reported Quarter Ended June 30 EPS $(0.09) Up From $(0.14) YoY; Revenue $163,163 Up From $141,237 YoY
Benzinga Newsdesk
